Organoids From Breast Cancer Patients Treated With Neoadjuvant Therapy
Recruiting
Observational Study
Invasive Breast Cancer
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 240 (estimated)
- Sponsor
- Istituti Clinici Scientifici Maugeri SpA · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of this study is to establish patient-derived organoid (PDO) and tumor tissue cultures from breast cancer patients, in order to create personalized, accurate, and reliable preclinical models capable of providing information on the diverse biomolecular portraits of breast cancer. These models may also be used to predict the achievement of pathological complete response after neoadjuvant che…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Female subjects;
* Confirmed diagnosis of breast heteroplasia
* Age 1\>= 8 years;
* Indication for neoadjuvant chemotherapy;
* Patients willing to follow the usual oncological follow-up;
* Patients with de novo metastatic disease (M+), receiving primary chemotherapy, if candid…
Contacts